Stoke Therapeutics Q2 EPS $(0.60) Down From $(0.39) YoY

Stoke Therapeutics (NASDAQ:STOK) reported quarterly losses of $(0.60) per share. This is a 53.85 percent decrease over losses of $(0.39) per share from the same period last year.

Stoke Therapeutics (NASDAQ:STOK) reported quarterly losses of $(0.60) per share. This is a 53.85 percent decrease over losses of $(0.39) per share from the same period last year.

Total
0
Shares
Related Posts